Fund Manager Summary on SDI Ltd (ASX:SDI)
SDI Ltd (ASX:SDI) presents an interesting investment proposition, characterized by both structural opportunities and operational challenges. Recent commentary indicates a phased exit from the lower-margin Amalgam product, positively impacting gross margins which have risen to 63%. A significant focus is on the new manufacturing facility, expected to drive efficiencies and future growth, despite presenting balance sheet and development risks due to increased debt levels. Investors remain cautious about potential capital raises, though many perceive SDI’s current trading valuation at approximately 10-11x earnings as attractive, underscoring the likelihood for a re-rating post-transition. With its strong Australian cost base and global revenue streams, SDI is positioned well to capitalize on market fluctuations, offering a compelling outlook amid noted operational headwinds.
Commentary From The Managers
There are 4 insights from 2 fund managers regarding their investment in SDI Ltd (ASX:SDI) available on Thesis Tracker.
Unlock Updates With ThesisTracker Pro
Don’t let information asymmetry undermine your investment returns. Join other engaged investors on ThesisTracker Pro.
Updates are made available to members within 12 hours of being released. The completeness, accuracy or current status of the investments referenced are not guaranteed.
Commentary From The Managers
The completeness, accuracy or current status of the investments referenced are not guaranteed.
Investment Ideas Scanner
Fund managers: Camplify (ASX:CHL) nearing inflection point after PaulCamper fixes
Why fund managers now back Senetas (ASX:SEN): post-Votiro sale, profitable & cash-rich
Challenger Gold (ASX:CEL) — Jan 2026 toll milling, imminent cash flow & 46% upside
L1 Capital (Jun 2025): Chorus Ltd (ASX:CNU) — FTTH complete, FCF lift & 21% dividend
Dec 2025 fund view: Southern Palladium (ASX:SPD) — palladium supply deficit fuels 110% rally
Paradice: Why Bannerman Energy (ASX:BMN) is a core, low‑cost Etango uranium play
WAM Jan 2026: CD Equity Fund II (ASX:CD2) exit triggers 38¢ distribution
Why fund managers back Beamtree (ASX:BMT): NHS tie-up, $30m+ ARR forecast
Ventia (ASX:VNT): FY26 guidance, 87% revenues secured & margin upgrade
Why fund managers highlight IMB (ASX:IMB): FY25 $38.6m EBITDA & strong cashflow
Frequently Asked Questions
Who is investing in SDI Ltd (ASX:SDI)?
Fund managers including Mereweather Capital and DMX Asset Management have invested in SDI Ltd (ASX:SDI).
Why do fund managers invest in SDI Ltd?
Fund managers invest in SDI Ltd due to its solid gross margins, which recently improved to 63%, alongside a relatively low earnings multiple of 9.5x to 10x. Despite some sales challenges, particularly in its declining Amalgam product line, the company shows resilience with core segments growing. Its Australian-based manufacturing provides stability, and global sales exposure can be advantageous in a fluctuating currency environment. Upcoming expansion in manufacturing capacity points to potential future growth, making it an attractive risk/reward opportunity.
What happened to SDI Ltd (ASX:SDI)?
Fund managers are investing in SDI Ltd due to its established position as a manufacturer of high-quality dental materials, combined with strong gross margins and a global revenue base. Despite a small market capitalization and low liquidity, SDI's proactive management and ongoing manufacturing expansion present significant growth opportunities. The company's focus on innovative dental solutions and a capital-light model enhances its attractiveness, particularly as it navigates current market pressures without resorting to equity raises. This strategic positioning is expected to lead to improved earnings and healthy dividend yields in the future.
What is the short interest in SDI Ltd (ASX:SDI)?
According to ASIC filings, there is negligible or no short interest in SDI Ltd (ASX:SDI).
What does SDI Ltd (ASX:SDI) do?
SDI Ltd. engages in the research, development, manufacturing, distribution, and marketing of dental restorative products, tooth whitening systems, and other dental materials. It operates through the following geographical segments: Australia, Europe, USA, and Brazil. The company was founded by Jeffery James Cheetham, Pamela Joy Cheetham and Hendrik Strydom in 1972 and is headquartered in Melbourne, Australia.